Join the 'Melanoma - Metastatic' group to help and get support from people like you.
Melanoma - Metastatic News
AI Better Than Docs at Catching Skin Cancers
Posted 31 May 2018 by Drugs.com
THURSDAY, May 31, 2018 – A computer can beat even highly experienced dermatologists in spotting deadly melanomas, researchers report. The study is the latest to test the idea that "artificial intelligence" can improve medical diagnoses. Typically, it works like this: Researchers develop an algorithm using "deep learning" – where the computer system essentially mimics the brain's neural ...
How to Do a Self-Check for Skin Cancer
Posted 27 May 2018 by Drugs.com
SATURDAY, May 26, 2018 – Learning how to do a skin self-exam could save your life. "Skin cancer is one of the few cancers you can see with the naked eye," said Dr. Ali Hendi, an assistant clinical professor of dermatology at Georgetown University Medical Center in Washington, D.C. "Yet sadly, many people don't know how to be their own hero when it comes to skin cancer, including what to look for ...
Another Foe for the U.S. Military: Skin Cancer
Posted 24 May 2018 by Drugs.com
THURSDAY, May 24, 2018 – For U.S. military personnel, deployment carries many dangers. And besides the well-known threats they face, these men and women are also at a higher-than-average risk for skin cancer, including potentially deadly melanoma, a new research review suggests. Two military groups face a particularly high risk: white service members and men over 50, according to the report. ...
Men May Gain More From Cancer Immunotherapy
Posted 17 May 2018 by Drugs.com
THURSDAY, May 17, 2018 – Male cancer patients seem to fare significantly better following immunotherapy treatment than female patients, new research indicates. "Both sex and gender can potentially affect the strength of the body's immune response," explained study author Dr. Fabio Conforti, from the European Institute of Oncology in Milan, Italy. For example, Conforti noted that women generally ...
Outdoor Job? Skin Cancer Can Take a Hefty Toll
Posted 27 Apr 2018 by Drugs.com
FRIDAY, April 27, 2018 – Construction workers, farmers and others who work in the sun are at greater risk for skin cancer, according to researchers. And a new study reveals these job-related cancers cost nations millions in medical expenses. The researchers said lawmakers should address this trend and take steps to reduce job-related exposure to the sun's harmful ultraviolet rays. "The findings ...
Marriage Means 'I Do' for Skin Cancer Detection
Posted 18 Apr 2018 by Drugs.com
WEDNESDAY, April 18, 2018 – A walk down the aisle may be a healthy step to better skin cancer detection. New research shows that simply by being married, people increase their odds that a melanoma – the most deadly form of skin cancer – will be spotted early, when it's most treatable. The reason? A husband or wife may help "by assisting in identification of pigmented lesions that may have ...
Drug Keytruda May Help Block Melanoma's Return
Posted 16 Apr 2018 by Drugs.com
MONDAY, April 16, 2018 – Taking the drug Keytruda after surgery for advanced melanoma significantly reduced patients' risk of their cancer returning, a new study found. Last May, Keytruda (pembrolizumab) became the first ever drug approved by the U.S. Food and Drug Administration to fight cancers based on specific tumor genetics, rather than where in the body the tumor occurs. The drug also ...
Task Force Issues Stronger Skin Cancer Prevention Guidelines
Posted 20 Mar 2018 by Drugs.com
TUESDAY, March 20, 2018 – Doctors should start early with skin cancer prevention advice when their patients are light-skinned, suggests new guidelines that bump that starting point back to the age of 6 months. This recommendation, from the U.S. Preventive Services Task Force, updates a 2012 recommendation that advised doctors not begin this education until children reached the age of 10. ...
Bristol-Myers Squibb’s Opdivo (nivolumab) Now the First and Only FDA-Approved PD-1 Inhibitor to Offer Every Four-Week Dosing
Posted 14 Mar 2018 by Drugs.com
PRINCETON, N.J.--(BUSINESS WIRE) March 6, 2018 --Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) updating the Opdivo (nivolumab) dosing schedule to include 480 mg infused every four weeks (Q4W) for a majority of approved indications.1 This approval will provide health care ...
Defense Against Skin Cancer May Live on Your Skin
Posted 28 Feb 2018 by Drugs.com
WEDNESDAY, Feb. 28, 2018 – Bacteria that commonly live on your skin's surface just might be protecting you from cancer. Researchers from the University of California, San Diego, said that one particular strain of bacteria appears to help ward off skin cancer by suppressing the spread of tumor cells triggered by over-exposure to the sun's ultraviolet (UV) rays. The new research, based on studies ...
It May Be Winter, But Keep That Sunscreen Handy
Posted 11 Feb 2018 by Drugs.com
SATURDAY, Feb. 10, 2018 – Just because it's not summer doesn't mean you're safe from sun-related skin damage. "The highest level of concern is usually during the summer months, but sun damage can occur year-round, even on cloudy or rainy days," said dermatologist Dr. Sarah Taylor, an assistant professor at Wake Forest Baptist Medical Center in Winston-Salem, N.C. "In fact, many people don't ...
Melanoma Rates Rising for Boomers, Falling Among Young
Posted 5 Feb 2018 by Drugs.com
MONDAY, Feb. 5, 2018 – It looks like public health efforts to warn younger Americans about the dangers of tanning beds and sun exposure are paying off. Rates of the deadly skin cancer known as melanoma have dropped among Americans aged 15 to 44, a new report from the U.S. Centers for Disease Control and Prevention shows. Unfortunately, baby boomers who baked themselves in baby oil during their ...
Bristol-Myers Squibb Receives FDA Approval for Opdivo (nivolumab) as Adjuvant Therapy in Patients with Completely Resected Melanoma with Lymph Node Involvement or Metastatic Disease
Posted 17 Jan 2018 by Drugs.com
PRINCETON, N.J.--(BUSINESS WIRE)-- December 20, 2017 Bristol-Myers Squibb Company (NYSE:BMY) announced today that the U.S. Food and Drug Administration (FDA) has approved Opdivo (nivolumab) injection for intravenous use for the adjuvant treatment of patients with melanoma with involvement of lymph nodes or metastatic disease who have undergone complete resection.1 The purpose of adjuvant therapy ...
Health Tip: Perform Regular Skin Checks
Posted 15 Jan 2018 by Drugs.com
-- Many skin cancers can be found early if you perform regular skin checks at home, the American Cancer Society says. The best time to do a monthly exam is right after a bath or shower. You should check for any new or changed moles, blemishes or birthmarks. Here are the Cancer Society's suggestions for performing a skin check: Face a mirror and check your face, ears, neck, chest and belly. Women ...
Firefighters May Face Higher Odds for Skin Cancer
Posted 13 Dec 2017 by Drugs.com
WEDNESDAY, Dec. 13, 2017 – Exposure to firefighting chemicals may be one reason why Florida firefighters have a higher-than-normal rate of skin cancer, a new study suggests. The researchers analyzed data from almost 2,400 firefighters statewide who'd participated in a cancer survey. They found that 4.5 percent – 109 firefighters – had been diagnosed with skin cancer. That included 17 cases of ...
Further Information
Related Condition Support Groups
Related Drug Support Groups
isotretinoin, Opdivo, Keytruda, nivolumab, Zelboraf, Yervoy, PegIntron, pembrolizumab, vemurafenib, view more... Sylatron, Proleukin, DTIC-Dome, aldesleukin, Tafinlar, peginterferon alfa-2b, Mekinist, Imlygic, cobimetinib, dacarbazine, talimogene laherparepvec, trametinib, dabrafenib, ipilimumab, temozolomide, Cotellic
